NCT03528941 2022-05-12
LLC1618
Gruppo Italiano Malattie EMatologiche dell'Adulto
Completed
Clinical Trials
5 trialsNCT01528865 2016-03-11
Safety & Efficacy of Lamivudine & Tenofovir to Lower Plasma Level of Viral RNA in Lymphoma
University of Michigan Rogel Cancer Center
Phase 1/2 Withdrawn
NCT00041327 2016-02-03
Combination Chemotherapy Followed By Antiviral Therapy and Interferon Alfa in Treating Patients With HTLV-1-Related Adult T-Cell Leukemia/Lymphoma
AIDS Malignancy Consortium
Phase 2 Completed
NCT01210287 2014-01-08
IHBVRL
Fudan University
Phase 2/3 Unknown
NCT01914744 2013-08-02
Entecavir Versus Lamivudine for Preventing the Risk of Hepatitis B Reactivation in NHL
Fudan University
Phase 2 Unknown